[Cost effectiveness of atorvastatin for prevention of coronary disease--an analysis of the ASCOT study. Re: the article from DMW 25/26 2004].
Traut
Volker
V
D000924:Anticholesteremic Agents / Q000191:economics* / Q000627:therapeutic use*; D000069059:Atorvastatin; D003327:Coronary Disease / Q000191:economics / Q000517:prevention & control*; D003362:Cost-Benefit Analysis; D006538:Heptanoic Acids / Q000191:economics* / Q000627:therapeutic use*; D006801:Humans; D011758:Pyrroles / Q000191:economics* / Q000627:therapeutic use*; D016896:Treatment Outcome
D000924:Anticholesteremic Agents; D006538:Heptanoic Acids; D011758:Pyrroles; D000069059:Atorvastatin
Kosteneffektivität von Atorvastatin zur Prävention der koronaren Krankheit--Eine Analyse der ASCOT-Studie. Zum Beitrag aus DMW 25/26 2004.